CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- 4/A Insider Changes in Ownership
- 4 Returned to the company Chief Financial Officer returned 11,175 shares (to the company)
- 4 Grant or award SVP Enterprise Transformation acquired 30,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award SVP Technology acquired 10,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Scientific Officer sold 80,000 shares at $29.71 ($2,377,048)
- 4 Open-market sale EVP Strategy and Innovation sold 11,824 shares at $25.00 ($295,600)
- 4 Grant or award Director acquired 15,889 shares (grant or award)
- 4 Grant or award Director acquired 15,889 shares (grant or award)
- 4 Grant or award Director acquired 15,889 shares (grant or award)
- 4 Grant or award Director acquired 15,889 shares (grant or award)
- 4 Grant or award Director acquired 15,889 shares (grant or award)
- 4 Grant or award Director acquired 15,889 shares (grant or award)
- 4 Grant or award Director acquired 15,889 shares (grant or award)
- 4 Open-market buy Director bought 15,000 shares at $16.62 ($249,336)
- 4 Returned to the company EVP Strategy and Innovation returned 2,218 shares (to the company)
- 4 Grant or award Executive VP Human Resources acquired 17,853 shares (grant or award)
- 4 Grant or award EVP Strategy and Innovation acquired 21,730 shares (grant or award)
- 4 Grant or award E.V.P., General Counsel acquired 29,784 shares (grant or award)
Page 20 of 65 · 1,294 filings